Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Elsayed

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Artificial Intelligence|September 15, 2025
Limitations of broadly trained LLMs in interpreting orthopedic Walch glenoid classificationsAdam ElSayed, Gary F Updegrove
Targeted Oncology|January 29, 2025
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic OptionsSarah Mettias, Adam ElSayed, Jonathan Moore, et al.
Journal of Orthopaedics|January 15, 2026
Do patients outlive their shoulder prosthesis?Tarek Haj Shehadeh, Adam Elsayed, Gary Updegrove, et al.
Perspectives in Clinical Research|May 5, 2025
Medical writing bias in myeloma clinical research: A comprehensive analysisAdam ElSayed, Sarah Mettias, Ryan Danis, et al.
Cureus|April 20, 2026
Enhancing Health Literacy in Endourology: Using Artificial Intelligence to Improve Readability of Patient Education MaterialsLoui Othman, Amar Kassim, Andrea Shehaj, et al.
European Journal of Haematology|July 24, 2023
Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective studyBernard Sean Regidor, Scott Jew, Marissa-Skye Goldwater, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Artificial Intelligence|September 15, 2025
Limitations of broadly trained LLMs in interpreting orthopedic Walch glenoid classificationsAdam ElSayed, Gary F Updegrove
Targeted Oncology|January 29, 2025
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic OptionsSarah Mettias, Adam ElSayed, Jonathan Moore, et al.
Journal of Orthopaedics|January 15, 2026
Do patients outlive their shoulder prosthesis?Tarek Haj Shehadeh, Adam Elsayed, Gary Updegrove, et al.
Perspectives in Clinical Research|May 5, 2025
Medical writing bias in myeloma clinical research: A comprehensive analysisAdam ElSayed, Sarah Mettias, Ryan Danis, et al.
Cureus|April 20, 2026
Enhancing Health Literacy in Endourology: Using Artificial Intelligence to Improve Readability of Patient Education MaterialsLoui Othman, Amar Kassim, Andrea Shehaj, et al.
European Journal of Haematology|July 24, 2023
Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective studyBernard Sean Regidor, Scott Jew, Marissa-Skye Goldwater, et al.
Pageof 1